THDBH120 injection

DRUG3 trials

Sponsors

Tonghua Dongbao Pharmaceutical Co.,Ltd

Conditions

Diabetes Mellitus Type 2ObesityOverweight or Obese

Phase 1

Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity

CompletedNCT06951945

Tonghua Dongbao Pharmaceutical Co.,LtdObesity

Start: 2024-07-18End: 2024-12-23Updated: 2025-04-30

Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM

CompletedNCT07020949

Tonghua Dongbao Pharmaceutical Co.,LtdDiabetes Mellitus Type 2

Start: 2024-06-13End: 2024-11-27Updated: 2025-06-13

Phase 2

Phase II Study of THDBH120 Injection in Overweight or Obese Subjects

RecruitingNCT07036601

Tonghua Dongbao Pharmaceutical Co.,LtdOverweight or Obese

Start: 2025-01-06End: 2026-03-11Target: 276Updated: 2025-06-25